Thymoquinone, betulinic acid, and gemcitabine pretreatments, together with gemcitabine, effectively inhibited the growth of cancer cells in vitro by downregulating the expression of PKM2, a promising part of cellular metabolism [88]. This evidence concerns the gene PKM and cancer.